| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |